Table 8.
Xenogeneic rejection mechanism of orthotopic corneal xenotransplantation in pig-to-small or medium sized animal model.
Recipient type | References | Type (PKP/lamellar) | Donor pig breed | Recipient | Donor size (mm) | N | MST (Days) | Histology of the rejected grafts/plasma |
---|---|---|---|---|---|---|---|---|
Rat | Lee et al. (2007) | PLK | Landrace | rat | 6.0 | 21 | 8.8 |
|
Lee et al. (2008) | PLK | Domestic | Sprague-Dawley rat | 6.0 | 21 | 9.3 |
|
|
Sprague-Dawley rat (+ISa) | 70 | 9.1 | ||||||
Oh et al. (2009b) | PLK | SNU miniature | Sprague–Dawley rat | 5.0 | 5 | 9.7 |
|
|
Sprague–Dawley rat (+allogeneic rat MSC) | 5 | 10.5 | ||||||
Lee et al. (2010) | IST | Domestic | Sprague–Dawley rat (+topical steroid) | 2.0 | 40 | 14.0 |
|
|
Mouse | Oh et al. (2009a) | PLK | SNU miniature | BALB/c | 3.0 | 10 | 9.0 | |
C57BL/6 | 12 | 9.0 |
|
|||||
Athymic Nude | 10 | 16.0c |
|
|||||
SCID | 12 | 16.4c |
|
|||||
NOG | 5 | 16.9 |
|
|||||
Oh et al. (2010) | PLK | Domestic | C57BL/6 | 3.0 | 18 | 9.4 |
|
|
SCID | 18 | 16.4 |
|
|||||
C57BL/6 (+CVF) | 18 | 15.5d |
|
|||||
SCID (+CVF) | 18 | 20.5d |
|
|||||
Choi et al. (2011a) | PLK | SNU miniature | C57BL/6 | 2.5 | 4 | 8 |
|
|
GT-KO (H-2b) | 4 | 9 |
|
|||||
medium | Oh et al. (2008) | ALK | SNU miniature | rabbit | 6.0 | 10 | 19-28b |
|
Oh et al. (2009c) | ALK | SNU miniature | rabbit | 7.0 | 8 | 29.1e |
|
|
PKP | 7.5 | 8 | 16.8 |
|
||||
Oh et al. (2009d) | ALK | SNU miniature | rabbit | 8.0 | 7 | 28 |
|
Abbreviations: Ab: antibody, αGal: Galα1-3Galβ1-4GlcNAc-R, ALK: anterior lamellar keratoplasty, CD: cluster of differentiation, CVF: cobra venom factor, D: days, HPF: high power field, GT-KO: α1,3-galactosyltransferase gene-knockout, IS: Immunosuppressant, IST: intrastromal transplantation, M: months, MSC: mesenchymal stem cells, MST: median survival time, N: number of animals experimented, NK: natural killer, NOG: NOD/SCID/γcnull, PLK: posterior lamellar keratoplasty, PMN: polymorphonuclear, SCID: severe combined immunodeficiency, SNU: Seoul National University, WT: wild-type.
Variable combinations of Immunosuppressant applied based on as follows; systemic cyclosporin A 1.25–10.0 mg/kg, dexamethasone 1.0–2.0 mg/kg, Mycophenolate mofetil 1.25 mg/kg.
MST is not available.
Statistically significant longer survival compared with that of control.
Statistically significant longer survival compared with that of control (B6 vs B6+CVF; SCID vs SCID + CVF).
Statistically significant longer survival of ALK compared with that of PKP.